CMPX
Companies
NASDAQ
Compass Therapeutics Inc.
Health Care
$2.38
+$0.93 (+64.14%)
Price Chart
Overview
About CMPX
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
Market Cap
$180.2M
Volume
2.4M
Avg. Volume
2.7M
P/E Ratio
-4.117647
Dividend Yield
0.00%
Employees
33.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.79
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CMPX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$180.2M
Volume2.4M
P/E Ratio-4.12
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025